+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transdermal Skin Patches Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery

  • ID: 5353026
  • Report
  • June 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Accrux Ltd.
  • Becton Dickinson Company
  • Elcam Medical
  • GSK
  • Luye Pharma Group Ltd.
  • Rusan Pharma (India)
Transdermal Skin Patches Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global transdermal skin patches market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the transdermal skin patches? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transdermal skin patches market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider transdermal skin patches market, and compares it with other markets.

1. Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
2. Report Structure - This section gives the structure of the report and the information covered in the various sections.
3. Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by product, segmentation by type and segmentation by application.
4. Market Characteristics - The market characteristics section of the report defines and explains the transdermal skin patches market. This chapter also defines and describes goods and related services covered in the report.
5. Trends and Strategies - This chapter describes the major trends shaping the global transdermal skin patches market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
6. Impact of COVID-19 - This section describes the impact of COVID-19 on the transdermal skin patches market.
7. Global Market Size and Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
8. Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
9. Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
10. Global Macro Comparison - The global transdermal skin patches market comparison with macro-economic factors gives the Transdermal Skin Patches market size, percentage of GDP, and average Transdermal Skin Patches market expenditure.
11. Regional Market Size and Growth - This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
12. Competitive Landscape - This section covers details on the competitive landscape of the global transdermal skin patches market, estimated market shares and company profiles for the leading players.
13. Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
14. Market Opportunities and Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
15. Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for biologics companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
16. Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Product: Matrix; Drug In Adhesive; Reservoir; Vapor
2) By Type: Fentanyl Transdermal Patch; Nicotine Transdermal Patch; Estradiol Transdermal Patch; Clonidine Transdermal Patch; Testosterone Transdermal Patch; Others
3) By Application: Pain Relief; Nicotine Cessation; Hormone Replacement Therapy; Neurological Disorders; Cardiovascular Disorders; Others

Companies Mentioned: Novartis; Hisamitsu Pharmaceutical; Hercon Pharmaceuticals; Mylan Pharmaceuticals Inc. (Viatris Inc.); The 3M Company

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; United States

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; transdermal skin patches indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accrux Ltd.
  • Becton Dickinson Company
  • Elcam Medical
  • GSK
  • Luye Pharma Group Ltd.
  • Rusan Pharma (India)

1. Transdermal Skin Patches Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Product
6.3. Segmentation By Type
6.4. Segmentation By Application
7. Transdermal Skin Patches Market Characteristics
7.1. Market Definition
7.2. Segmentation By Product
7.2.1. Matrix
7.2.2. Drug In Adhesive
7.2.3. Reservoir
7.2.4. Vapor
7.3. Segmentation By Type
7.3.1. Fentanyl Transdermal Patch
7.3.2. Nicotine Transdermal Patch
7.3.3. Estradiol Transdermal Patch
7.3.4. Clonidine Transdermal Patch
7.3.5. Testosterone Transdermal Patch
7.3.6. Others
7.4. Segmentation By Application
7.4.1. Pain Relief
7.4.2. Nicotine Cessation
7.4.3. Hormone Replacement Therapy
7.4.4. Neurological Disorders
7.4.5. Cardiovascular Disorders
7.4.6. Others
8. Transdermal Skin Patches Market Trends and Strategies
8.1. Advancements In Nicotine Transdermal Patches
8.2. Collaborations and Partnerships
8.3. Robust Research & Development
8.4. New Iontophoresis Patches
9. Impact Of COVID-19 On The Transdermal Skin Patches Market
9.1. Introduction
9.2. Impact On Manufacturing Of Transdermal Skin Patches
9.3. Development Of Microarray Patches For Skin-Targeted Vaccines For COVID-19
9.4. Conclusion
10. Global Transdermal Skin Patches Market Size and Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015 - 2020
10.2.2. Restraints On The Market 2015 - 2020
10.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
10.3.1. Drivers Of The Market 2020 - 2025
10.3.2. Restraints On The Market 2020 - 2025
11. Global Transdermal Skin Patches Market Segmentation
11.1. Global Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.1.1. Drug In Adhesive
11.1.2. Matrix
11.1.3. Reservoir
11.1.4. Vapor
11.2. Global Transdermal Skin Patches Market, 2019, By Type, Value ($ Million)
11.3. Global Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.3.1. Pain Relief
11.3.2. Neurological Disorders
11.3.3. Hormone Replacement Therapy
11.3.4. Nicotine Cessation
11.3.5. Cardiovascular Disorders
11.3.6. Others
12. Transdermal Skin Patches Market, Regional and Country Analysis
12.1. Global Transdermal Skin Patches Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12.2. Global Transdermal Skin Patches Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13. Asia-Pacific Transdermal Skin Patches Market
13.1. Asia-Pacific Transdermal Skin Patches Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. COVID-19 Impact
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Taxes Levied
13.1.10. Corporate Tax Structure
13.1.11. Investments
13.1.12. Major Companies
13.2. Asia-Pacific Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.3. Asia-Pacific Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.4. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.6. Asia-Pacific Transdermal Skin Patches Market: Country Analysis
13.7. China Transdermal Skin Patches Market
13.8. China Transdermal Skin Patches Market Overview
13.8.1. Country Information
13.8.2. Market Information
13.8.3. COVID-19 Impact
13.8.4. Background Information
13.8.5. Regulations
13.8.6. Regulatory Bodies
13.8.7. Major Associations
13.8.8. Taxes Levied
13.8.9. Corporate Tax Structure
13.8.10. Investments
13.8.11. Major Companies
13.9. China Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.10. China Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.11. China Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.12. China Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.13. India Transdermal Skin Patches Market
13.14. India Transdermal Skin Patches Market Overview
13.14.1. Country Information
13.14.2. Market Information
13.14.3. COVID-19 Impact
13.14.4. Background Information
13.14.5. Government Initiatives
13.14.6. Regulations
13.14.7. Regulatory Bodies
13.14.8. Major Associations
13.14.9. Taxes Levied
13.14.10. Corporate Tax Structure
13.14.11. Investments
13.14.12. Major Companies
13.15. India Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.16. India Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.17. India Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.18. India Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.19. Japan Transdermal Skin Patches Market
13.20. Japan Transdermal Skin Patches Market Overview
13.20.1. Country Information
13.20.2. Market Information
13.20.3. COVID-19 Impact
13.20.4. Background Information
13.20.5. Regulations
13.20.6. Regulatory Bodies
13.20.7. Major Associations
13.20.8. Taxes Levied
13.20.9. Corporate Tax Structure
13.20.10. Investments
13.20.11. Major Companies
13.21. Japan Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.22. Japan Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.23. Japan Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.24. Japan Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.25. Australia Transdermal Skin Patches Market
13.26. Australia Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.27. Australia Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.28. Australia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.29. Australia Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.30. Indonesia Transdermal Skin Patches Market
13.31. Indonesia Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.32. Indonesia Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.33. Indonesia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.34. Indonesia Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.35. South Korea Transdermal Skin Patches Market
13.36. South Korea Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.37. South Korea Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
13.38. South Korea Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.39. South Korea Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14. Western Europe Transdermal Skin Patches Market
14.1. Western Europe Transdermal Skin Patches Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. COVID-19 Impact
14.1.4. Background Information
14.1.5. Regulations
14.1.6. Regulatory Bodies
14.1.7. Major Associations
14.1.8. Taxes Levied
14.1.9. Corporate Tax Structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.3. Western Europe Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.4. Western Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.5. Western Europe Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.6. Western Europe Transdermal Skin Patches Market: Country Analysis
14.7. UK Transdermal Skin Patches Market
14.8. UK Transdermal Skin Patches Market Overview
14.8.1. Country Information
14.8.2. Market Information
14.8.3. COVID-19 Impact
14.8.4. Background Information
14.8.5. Regulations
14.8.6. Regulatory Bodies
14.8.7. Major Associations
14.8.8. Taxes Levied
14.8.9. Corporate Tax Structure
14.8.10. Investments
14.8.11. Major Companies
14.9. UK Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.10. UK Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.11. UK Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.12. UK Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.13. Germany Transdermal Skin Patches Market
14.14. Germany Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.15. Germany Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.16. Germany Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.17. Germany Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.18. France Transdermal Skin Patches Market
14.19. France Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.20. France Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.21. France Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.22. France Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15. Eastern Europe Transdermal Skin Patches Market
15.1. Eastern Europe Transdermal Skin Patches Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. COVID-19 Impact
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory bodies
15.1.8. Major Associations
15.1.9. Taxes levied
15.1.10. Corporate tax structure
15.1.11. Investments
15.1.12. Major Companies
15.2. Eastern Europe Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.3. Eastern Europe Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
15.4. Eastern Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.5. Eastern Europe Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.6. Eastern Europe Transdermal Skin Patches Market: Country Analysis
15.7. Russia Transdermal Skin Patches Market
15.8. Russia Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.9. Russia Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
15.10. Russia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.11. Russia Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16. North America Transdermal Skin Patches Market
16.1. North America Transdermal Skin Patches Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. COVID-19 Impact
16.1.4. Background Information
16.1.5. Government initiatives
16.1.6. Regulations
16.1.7. Regulatory Bodies
16.1.8. Major Associations
16.1.9. Investments
16.1.10. Taxes Levied
16.1.11. Corporate Tax Structure
16.1.12. Major Companies
16.2. North America Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.3. North America Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
16.4. North America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.5. North America Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.6. North America Transdermal Skin Patches Market: Country Analysis
16.7. USA Transdermal Skin Patches Market
16.8. USA Transdermal Skin Patches Market Overview
16.8.1. Country Information
16.8.2. Market Information
16.8.3. COVID-19 Impact
16.8.4. Background Information
16.8.5. Regulations
16.8.6. Regulatory Bodies
16.8.7. Major Associations
16.8.8. Investments
16.8.9. Corporate Tax Structure
16.8.10. Major Companies
16.9. USA Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.10. USA Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
16.11. USA Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.12. USA Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17. South America Transdermal Skin Patches Market
17.1. South America Transdermal Skin Patches Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. COVID-19 Impact
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Major Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. South America Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.3. South America Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
17.4. South America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.5. South America Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.6. South America Transdermal Skin Patches Market: Country Analysis
17.7. Brazil Transdermal Skin Patches Market
17.8. Brazil Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.9. Brazil Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
17.10. Brazil Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.11. Brazil Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18. Middle East Transdermal Skin Patches Market
18.1. Middle East Transdermal Skin Patches Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. COVID-19 Impact
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory bodies
18.1.8. Major Associations
18.1.9. Investments
18.1.10. Taxes Levied
18.1.11. Corporate Tax Structure
18.1.12. Major Companies
18.2. Middle East Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.3. Middle East Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.4. Middle East Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.5. Middle East Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19. Africa Transdermal Skin Patches Market
19.1. Africa Transdermal Skin Patches Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. COVID-19 Impact
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Major Associations
19.1.9. Taxes Levied
19.1.10. Corporate Tax Structure
19.1.11. Investments
19.1.12. Major Companies
19.2. Africa Transdermal Skin Patches Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
19.3. Africa Transdermal Skin Patches Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
19.4. Africa Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.5. Africa Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20. Global Transdermal Skin Patches Market Competitive Landscape
20.1. Company Profiles
20.2. Novartis
20.2.1. Company Overview
20.2.2. Products and Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Hisamitsu Pharmaceutical
20.3.1. Company Overview
20.3.2. Products and Services
20.3.3. Business Strategy
20.3.4. Financial Performance
20.4. Hercon Pharmaceuticals
20.4.1. Company Overview
20.4.2. Products and Services
20.4.3. Financial Performance
20.5. Mylan N. V. (Viatris Inc.)
20.5.1. Company Overview
20.5.2. Products and Services
20.5.3. Business Strategy
20.5.4. Financial Performance
20.6. The 3M Company
20.6.1. Company Overview
20.6.2. Products and Services
20.6.3. Business Strategy
20.6.4. Financial Performance
21. Key Mergers and Acquisitions In The Transdermal Skin Patches Market
21.1. Nutriband Inc Acquired Pocono Coated Products
21.2. Luye Pharma Group Acquired Shandong Boan Biological Technology Co. Ltd (Boan)
21.3. Canoa Acquired ProSolus
21.4. Mylan Mergered With Pfizer's Upjohn
21.5. Nutriband Inc Acquired 4P Therapeutics
22. Transdermal Skin Patches Market Opportunities and Strategies
22.1. Global Transdermal Skin Patches Market In 2025 - Countries Offering Most New Opportunities
22.2. Global Transdermal Skin Patches Market In 2025 - Segments Offering Most New Opportunities
22.3. Global Transdermal Skin Patches Market In 2025 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies
23. Transdermal Skin Patches Market, Conclusions and Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People
24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher
24.6. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accrux Ltd.
  • Becton Dickinson Company
  • Elcam Medical
  • GSK
  • Luye Pharma Group Ltd.
  • Rusan Pharma (India)
This report describes and explains the global transdermal skin patches market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

The global transdermal skin patches market reached a value of nearly $6,504.6 million in 2020, having increased at a compound annual growth rate (CAGR) of 3.9% since 2015. The market is expected to grow from $6,504.6 million in 2020 to $7,910.6 million in 2025 at a rate of 4.0%. The market is then expected to grow at a CAGR of 3.5% from 2025 and reach $9,390.0 million in 2030.

Growth in the historic period in the transdermal skin patches market resulted from non-invasive nature of treatment, advances in technology, increased geriatric population, strong economic growth in emerging markets, increase in pharmaceutical R&D expenditure, and increased healthcare expenditure. The market was restrained by political uncertainties, challenges due to regulatory changes and low healthcare reimbursements.

Going forward increase in smoking cessation, rapid growth in the geriatric population, rise in healthcare expenditure, and increase in cardiovascular diseases (CVDs) will drive the growth in the transdermal skin patches market. Factors that could hinder the growth of the market in the future include side effects, coronavirus pandemic and stringent regulatory approval.

The transdermal skin patches market is segmented by product into matrix, drug in adhesive, reservoir and vapor. The drug in adhesive was the largest segment of the transdermal skin patches market segmented by product, accounting for 40.9% of the total in 2020. Going forward, the reservoir segment is expected to be the fastest growing segment in the transdermal skin patches market segmented by product, at a CAGR of 5.9% during 2020-2025.

The transdermal skin patches market is also segmented by type into fentanyl transdermal patch, nicotine transdermal patch, estradiol transdermal patch, clonidine transdermal patch, testosterone transdermal patch, and others. The others market was the largest segment of the transdermal skin patches market segmented by type, accounting for 35.6% of the total in 2020.

The transdermal skin patches market is also segmented by application into pain relief, nicotine cessation, hormone replacement therapy, neurological disorders, cardiovascular disorders, and others. The pain relief market was the largest segment of the transdermal skin patches market segmented by application, accounting for 22.3% of the total in 2020. Going forward, hormone replacement therapy segment is expected to be the fastest growing segment in the transdermal skin patches market segmented by application, at a CAGR of 5.7% during 2020-2025.

North America was the largest region in the transdermal skin patches market, accounting for 36.2% of the total in 2020. It was followed by the Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the transdermal skin patches market will be South America and Africa where growth will be at CAGRs of 7.3% and 6.6% respectively during 2020-2025. These will be followed by Asia-Pacific and Eastern Europe, where the markets are expected to register CAGRs of 5.2% and 5.1% respectively during 2020-2025.

Transdermal patches are a non-invasive method of self-administrating medication. Transdermal drugs release a small number of drugs into the bloodstream over a long period. These skin patch drugs include nicotine, relievers, drugs, and hormones to treat various conditions such as angina and motion sickness among others. The COVID-19 pandemic profoundly affected the healthcare sector across the globe. The healthcare organizations on the front line of the emergency are focused on effective treatment and quick recovery of infected patients to reduce the burden on infrastructure throughout the pandemic. Non-frontline healthcare institutions observed a downfall in elective procedures and focus on the treatment of other diseases due to concerns over the contraction of the virus.

The global transdermal skin patches market is concentrated, with a small number of global players operating in the market. The top ten competitors in the market made up to 38.79% of the total market in 2019. Major players in the market include Novartis, Hisamitsu Pharmaceutical, Hercon Pharmaceuticals, Mylan N. V. (Viatris Inc.), and The 3M Company.

The top opportunities in the transdermal skin patches market segmented by product will arise in the drug in adhesive segment, which will gain $695.3 million of global annual sales by 2025. The top opportunities in the transdermal skin patches market segmented by application will arise in hormone replacement therapy segment, which will gain $343.6 million of global annual sales by 2025. The transdermal skin patches market size will gain the most in the USA at $250.7 million.

Market-trend-based strategies for the transdermal skin patches includes invest in the development of advanced nicotine patches, carry out strategic collaborations and partnerships, investing extensively in R&D activities for the development of effective and innovative treatments, invest in dissolving microneedle patches, and development of new iontophoresis transdermal patches.

Player-adopted strategies in the transdermal skin patches market includes development of innovative products and addition of new formulations for existing products, new manufacturing facility establishments, development of effective generic versions of established versions, strategic collocation and agreements with technology players.

To take advantage of these opportunities, the publisher recommends the transdermal skin patches manufacturing companies to invest in development of nicotine transdermal patches and research and development to increase efficiency and develop innovative products, expand in low- and middle-income countries to target the untapped patient pools, provide competitive pricing, target hospital and pharmacies to spread awareness and target geriatric population among other strategies.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Novartis
  • Hisamitsu Pharmaceutical
  • Hercon Pharmaceuticals
  • Mylan Pharmaceuticals Inc. (Viatris Inc.)
  • The 3M Company
  • Teva Pharmaceuticals
  • Luye Pharma Group Ltd.
  • Henan Lingrui Pharmaceutical
  • Purdue Pharma L.P.
  • AdhexPharma
  • Accrux Ltd.
  • Access Pharmaceuticals Inc.
  • Rusan Pharma (India)
  • Glenmark Pharmaceuticals
  • Cipla Ltd
  • Grünenthal
  • UCB Pharma
  • Johnson & Johnson
  • Nitto Denko
  • GSK
  • IBSA Group
  • Bayer
  • Beijing Tide Pharmaceutical
  • Mundipharma
  • Dr Reddy’s Laboratories
  • Pfizer
  • Endo International
  • Chattem 
  • Allergan Inc.
  • Luye Pharma Group
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Acrux Limited
  • Echo Therapeutics Inc.
  • Teikoku Pharma
  • Antares Pharmaceutical Ltd.
  • Baxter International
  • Becton Dickinson Company
  • Elcam Medical
  • Eli Lily and Company
  • Unilife Corporation
  • West Pharmaceutical Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...